Andreas Pettersson1, Rebecca E Graff1, Giske Ursin1, Isabel Dos Santos Silva1, Valerie McCormack1, Laura Baglietto1, Celine Vachon1, Marije F Bakker1, Graham G Giles1, Kee Seng Chia1, Kamila Czene1, Louise Eriksson1, Per Hall1, Mikael Hartman1, Ruth M L Warren1, Greg Hislop1, Anna M Chiarelli1, John L Hopper1, Kavitha Krishnan1, Jingmei Li1, Qing Li1, Ian Pagano1, Bernard A Rosner1, Chia Siong Wong1, Christopher Scott1, Jennifer Stone1, Gertraud Maskarinec1, Norman F Boyd1, Carla H van Gils1, Rulla M Tamimi1. 1. Affiliations of authors: Department of Epidemiology (AP, REG, RMT), and Department of Biostatistics (BAR), Harvard School of Public Health, Boston, MA; Department of Nutrition, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway (GU); Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA (GU); Department of Non-Communicable Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, UK (IdSS); Section of Environment and Radiation, International Agency for Research on Cancer, Lyon, France (VM); Cancer Epidemiology Centre, Cancer Council Victoria, Melbourne, Australia (LB, GGG, KK); Centre for Molecular, Environmental, Genetic and Analytical Epidemiology, University of Melbourne, Melbourne, Australia (LB, GGG, JLH, KK, JS); Division of Epidemiology (CV) and Division of Biomedical Statistics and Informatics (CS), Department of Health Sciences Research, Mayo Clinic, Rochester, MN; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands (MFB, CHvG); Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, Australia (GGG); Saw Swee Hock School of Public Health (KSC, MH, CSW), and Department of Surgery, Yong Loo Lin School of Medicine (MH), National University of Singapore, National University Health System, Singapore, Singapore; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden (KC, LE, PH, MH); Department of Radiology, Addenbrooke's Hospital, Cambridge, UK (RMLW); School of Population and Public Health, University of British Columbia, Vancouver, BC , Canada (GH); Prevention and Cancer Control, Cancer Care, Toronto, ON, Canada (AMC); Human Genetics, Genome Institute of Singapore, Singapore, Singapore (JL); Campbell Family Institute for Breast Cancer Research, Ontario Cancer Institute, Toronto, ON, Canada (QL, NFB); University of Hawaii Cancer Center, Honolu
Abstract
BACKGROUND: Fibroglandular breast tissue appears dense on mammogram, whereas fat appears nondense. It is unclear whether absolute or percentage dense area more strongly predicts breast cancer risk and whether absolute nondense area is independently associated with risk. METHODS: We conducted a meta-analysis of 13 case-control studies providing results from logistic regressions for associations between one standard deviation (SD) increments in mammographic density phenotypes and breast cancer risk. We used random-effects models to calculate pooled odds ratios and 95% confidence intervals (CIs). All tests were two-sided with P less than .05 considered to be statistically significant. RESULTS: Among premenopausal women (n = 1776 case patients; n = 2834 control subjects), summary odds ratios were 1.37 (95% CI = 1.29 to 1.47) for absolute dense area, 0.78 (95% CI = 0.71 to 0.86) for absolute nondense area, and 1.52 (95% CI = 1.39 to 1.66) for percentage dense area when pooling estimates adjusted for age, body mass index, and parity. Corresponding odds ratios among postmenopausal women (n = 6643 case patients; n = 11187 control subjects) were 1.38 (95% CI = 1.31 to 1.44), 0.79 (95% CI = 0.73 to 0.85), and 1.53 (95% CI = 1.44 to 1.64). After additional adjustment for absolute dense area, associations between absolute nondense area and breast cancer became attenuated or null in several studies and summary odds ratios became 0.82 (95% CI = 0.71 to 0.94; P heterogeneity = .02) for premenopausal and 0.85 (95% CI = 0.75 to 0.96; P heterogeneity < .01) for postmenopausal women. CONCLUSIONS: The results suggest that percentage dense area is a stronger breast cancer risk factor than absolute dense area. Absolute nondense area was inversely associated with breast cancer risk, but it is unclear whether the association is independent of absolute dense area.
BACKGROUND: Fibroglandular breast tissue appears dense on mammogram, whereas fat appears nondense. It is unclear whether absolute or percentage dense area more strongly predicts breast cancer risk and whether absolute nondense area is independently associated with risk. METHODS: We conducted a meta-analysis of 13 case-control studies providing results from logistic regressions for associations between one standard deviation (SD) increments in mammographic density phenotypes and breast cancer risk. We used random-effects models to calculate pooled odds ratios and 95% confidence intervals (CIs). All tests were two-sided with P less than .05 considered to be statistically significant. RESULTS: Among premenopausal women (n = 1776 case patients; n = 2834 control subjects), summary odds ratios were 1.37 (95% CI = 1.29 to 1.47) for absolute dense area, 0.78 (95% CI = 0.71 to 0.86) for absolute nondense area, and 1.52 (95% CI = 1.39 to 1.66) for percentage dense area when pooling estimates adjusted for age, body mass index, and parity. Corresponding odds ratios among postmenopausal women (n = 6643 case patients; n = 11187 control subjects) were 1.38 (95% CI = 1.31 to 1.44), 0.79 (95% CI = 0.73 to 0.85), and 1.53 (95% CI = 1.44 to 1.64). After additional adjustment for absolute dense area, associations between absolute nondense area and breast cancer became attenuated or null in several studies and summary odds ratios became 0.82 (95% CI = 0.71 to 0.94; P heterogeneity = .02) for premenopausal and 0.85 (95% CI = 0.75 to 0.96; P heterogeneity < .01) for postmenopausal women. CONCLUSIONS: The results suggest that percentage dense area is a stronger breast cancer risk factor than absolute dense area. Absolute nondense area was inversely associated with breast cancer risk, but it is unclear whether the association is independent of absolute dense area.
Authors: Norman F Boyd; Lisa J Martin; Limei Sun; Helen Guo; Anna Chiarelli; Greg Hislop; Martin Yaffe; Salomon Minkin Journal: Cancer Epidemiol Biomarkers Prev Date: 2006-11 Impact factor: 4.254
Authors: Norman F Boyd; Helen Guo; Lisa J Martin; Limei Sun; Jennifer Stone; Eve Fishell; Roberta A Jong; Greg Hislop; Anna Chiarelli; Salomon Minkin; Martin J Yaffe Journal: N Engl J Med Date: 2007-01-18 Impact factor: 91.245
Authors: Norman Boyd; Lisa Martin; Anoma Gunasekara; Olga Melnichouk; Gord Maudsley; Chris Peressotti; Martin Yaffe; Salomon Minkin Journal: Cancer Epidemiol Biomarkers Prev Date: 2009-06 Impact factor: 4.254
Authors: Mariëtte Lokate; Petra H M Peeters; Linda M Peelen; Gerco Haars; Wouter B Veldhuis; Carla H van Gils Journal: Breast Cancer Res Date: 2011-10-26 Impact factor: 6.466
Authors: Said Pertuz; Elizabeth S McDonald; Susan P Weinstein; Emily F Conant; Despina Kontos Journal: Radiology Date: 2015-10-21 Impact factor: 11.105
Authors: Touseef A Qureshi; Harini Veeraraghavan; Janice S Sung; Jennifer B Kaplan; Jessica Flynn; Emily S Tonorezos; Suzanne L Wolden; Elizabeth A Morris; Kevin C Oeffinger; Malcolm C Pike; Chaya S Moskowitz Journal: J Med Syst Date: 2019-06-22 Impact factor: 4.460
Authors: Michael A Pinkert; Lonie R Salkowski; Patricia J Keely; Timothy J Hall; Walter F Block; Kevin W Eliceiri Journal: J Med Imaging (Bellingham) Date: 2018-01-22
Authors: Mark Sak; Neb Duric; Peter Littrup; Lisa Bey-Knight; Haythem Ali; Patricia Vallieres; Mark E Sherman; Gretchen L Gierach Journal: Ultrasound Med Biol Date: 2016-09-29 Impact factor: 2.998
Authors: Laurel A Habel; Weiva Sieh; Russell B McBride; Kezhen Fei; Joseph H Rothstein; Stacey E Alexeeff; Xiaoyu Song; Lori C Sakoda; Valerie McGuire; Ninah Achacoso; Luana Acton; Rhea Y Liang; Jafi A Lipson; Martin J Yaffe; Daniel L Rubin; Alice S Whittemore Journal: Cancer Epidemiol Biomarkers Prev Date: 2020-02-17 Impact factor: 4.254
Authors: Adetunji T Toriola; Catherine M Appleton; Xiaoyu Zong; Jingqin Luo; Katherine Weilbaecher; Rulla M Tamimi; Graham A Colditz Journal: Cancer Prev Res (Phila) Date: 2018-10-23
Authors: Kimberly A Bertrand; Heather J Baer; E John Orav; Catherine Klifa; Ajay Kumar; Nola M Hylton; Erin S LeBlanc; Linda G Snetselaar; Linda Van Horn; Joanne F Dorgan Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-05-09 Impact factor: 4.254
Authors: Seungyoun Jung; Olga Goloubeva; Catherine Klifa; Erin S LeBlanc; Linda G Snetselaar; Linda Van Horn; Joanne F Dorgan Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-05-19 Impact factor: 4.254